Thousands of children and young people in the United States struggle with lupus. The treatment of the condition requires…
Ines Martins, PhD
Inês holds a PhD in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in blood vessel biology, blood stem cells, and cancer. Before that, she studied Cell and Molecular Biology at Universidade Nova de Lisboa and worked as a research fellow at Faculdade de Ciências e Tecnologias and Instituto Gulbenkian de Ciência. Inês currently works as a Managing Science Editor, striving to deliver the latest scientific advances to patient communities in a clear and accurate manner.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ines Martins, PhD
Patients who suffer from systemic lupus erythematosus (SLE) or lupus nephritis (LN) may have seven new therapeutic options…
Results from a survey conducted by GfK in 2014 indicated that patients with systemic lupus erythematosus (SLE) have difficulties describing…
May is Lupus Awareness Month and the Lupus Research Institute (LRI), the S.L.E. Lupus Foundation and the…
The S.L.E. Lupus Foundation is advocating for wider access to medication for patients who suffer from…
The Lupus Foundation of America is hosting another edition of its Walk to End Lupus Now,…
The non-profit organization Lupus Foundation of America continues the fight against lupus by supporting research projects seeking to discover…
This year’s edition of the New York Lupus Handbag Luncheon gathered over 350 people in a fundraising effort to help support…
Padlock Therapeutics, a firm focused on the development of new treatment alternatives for autoimmune conditions, recently announced a collaboration…
Breakthroughs in new treatments for lupus may be useless if patients do not have access to innovative therapies as…